Latest Update On Kure It Grants
This is a story of a modest seed grant from Kure It making a vital difference in cancer research, a difference much larger than anyone had imagined.
In 2017, Kure It provided a $100,000 “seed grant” for a collaboration between two physician scientist at UCI. The funds were designed for a study of gastric cancer.
One of the two UCI Physician scientist, Dr. Dayyani, began to collect patient donations of gastric tumor tissue for studies of drug sensitivities. Thus began the development of a precious resource, a biobank of gastric cancer research material.
As this resource was being developed, a new collaboration was proposed between four UC Cancer Centers: UCSF, UC Davis, UCLA and UCI. These four University of California Cancer Centers, together with UC San Diego, make up a consortium that treats 19 million cancer patients – making it the largest cancer center entity in the world.
Dr. Dayyani’s efforts to build a gastric cancer biobank using Kure It funding were immediately recognized as a very important step toward doing additional research. He was invited to participate in the new four-University collaboration and to submit a large request to the National Cancer Institute (NCI) so he could further develop the biobank.
The NCI grant was funded for over $6 million. Now, Dr. Dayyani is actively working with the collaboration to create a broader resource that will enable multiple scientists within the UC Cancer Center system to test new ideas for stomach cancer treatments.
Working With Researchers
In February 2018, Kure It hosted a Rivalry Retreat inviting researchers from USC Norris and UCLA Jonsson Comprehensive Cancer Centers to collaborate on the grants they received over that last 5 years through our Rivals United For A Kure campaign. Donors were invited to a reception later in the day to meet the researchers and hear the impact that has been made in underfunded cancer research. Hear from Dr. Alan Wayne, Interim Director of USC Norris, and the researchers how important Kure It grants are in finding a kure.
Meet the Researchers
Kure It’s mission is to be the leader in granting funds to scientists researching kidney cancer and other underfunded cancers. These researchers receive “seed monies” to explore innovative research projects. Learn more about these brilliant individuals that have made advances in eradicating cancer.
We Have Granted Funds to Investigate:
- Bladder Cancer
- Cholanglocarcinoma (Bile Duct Cancer)
- Chondrosarcoma (Bone & Soft Tissue)
- Ewing Sarcoma (Pediatric Bone and Soft Tissue Cancer)
- Gallbladder Cancer
- Genetic Mutations in Adolescent & Young Adult Cancers
- Genetic Sequencing in Adolescent & Young Adult Cancers
- Head & Neck Cancers
- Immunotherapy in Melanoma
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Molecular Altercation in Liposarcoma (Deep Soft Tissue)
- Pediatric Neuroblastoma
- Prostate Cancer
- Spine Cancer
We Have Given Grants to the Following Institutions:
- Beth Israel Deaconess Medical Center, Boston, MA
- Case Western Reserve University, Cleveland, OH
- City of Hope, Duarte, CA
- Dana-Farber Cancer Institute, Boston, MA
- Knight Cancer Institute, Portland, OR
- UCI Chao Family Comprehensive Cancer Center, Irvine, CA
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
- USC Norris Comprehensive Cancer Center, Los Angeles, CA
- Vall d’Hebron Institute of Research, Barcelona, Spain
- Vanderbilt University Medical Center, Nashville, TN